Arch Biopartners (TSXV:ARCH) FCF Yield % : -1.58 (As of May. 01, 2024)

View and export this data going back to 2000. Start your Free Trial

What is Arch Biopartners FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Arch Biopartners's Trailing 12-Month Free Cash Flow is C$-1.78 Mil, and Market Cap is C$112.51 Mil. Therefore, Arch Biopartners's FCF Yield % for today is -1.58%.

The historical rank and industry rank for Arch Biopartners's FCF Yield % or its related term are showing as below:

TSXV:ARCH' s FCF Yield % Range Over the Past 10 Years
Min: -6.21 Med: -2.23 Max: -0.61
Current: -1.58

During the past 13 years, the highest FCF Yield % of Arch Biopartners was -0.61%. The lowest was -6.21%. And the median was -2.23%.

TSXV:ARCH's FCF Yield % is ranked better than
80.59% of 1551 companies
in the Biotechnology industry
Industry Median: -15.06 vs TSXV:ARCH: -1.58

Arch Biopartners's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Arch Biopartners FCF Yield % Historical Data

The historical data trend for Arch Biopartners's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners FCF Yield % Chart

Arch Biopartners Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

FCF Yield %

Get a 7-Day Free Trial

-3.09

-2.29

-2.81

0.26

-0.34

Arch Biopartners Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Yield %	Get a 7-Day Free Trial															-0.68	-2.68	1.82	-5.01	-2.35

Competitive Comparison of Arch Biopartners's FCF Yield %

For the Biotechnology subindustry, Arch Biopartners's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Arch Biopartners's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arch Biopartners's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Arch Biopartners's FCF Yield % falls into.

Arch Biopartners FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Arch Biopartners's FCF Yield % for the fiscal year that ended in Sep. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-0.234	/	68.232692
	=	-0.34%

Arch Biopartners's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-0.546	*	4	/	92.878288
	=	-2.35%

Arch Biopartners FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Arch Biopartners FCF Yield % Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners (TSXV:ARCH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (TSXV:ARCH) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.